VES – Regulatory issues with access to Medicines for Scleroderma – November 2024

In November’s session we will be discussing the the regulatory issues with access to Medicines for Scleroderma in Australia.

Dr Andrew Pengilley is a Public Health Physician with 24 years experience working in various areas of public health within the Commonwealth and State and Territory Governments. For the past five years he has been a Principal Medical Advisor at the Therapeutic Goods Administration (TGA), where he works as the head of the premarket evaluation section dealing with vaccines and anti-infectives. Prior to this Dr Pengilley worked in the ACT and Victorian Health Departments in areas dealing with infectious disease control, as well as in health promotion policy.

We look forward to you joining us.

Register for VES – Regulatory issues with access to Medicines for Scleroderma – November 2024